Clinical Trials Browser

Phase 1 × Solutions × Tumor-Agnostic × Clear all

NCT04675021 2021-01-26

Absolute Bioavailability and ADME Study of Savolitinib in Healthy Male Subjects

Phase 1 Completed

Neoplasms